Prescription for Reform: Kelvyn Cullimore on the Future of Drug Pricing and Innovation

Описание: Inside Pharma Policy: Kelvyn Cullimore on Drug Pricing, Innovation & Reform
In this exclusive PoliticIt interview, Kelvyn Cullimore—President & CEO of BioUtah—dives deep into the most pressing issues facing the pharmaceutical industry today. From the “Most Favored Nation” clause to the controversial “pill penalty,” Cullimore explains how recent legislative efforts may impact drug development, pricing, and access.

We discuss:
💊 Why U.S. drug prices are higher than in other countries
💡 The role of Pharmacy Benefit Managers (PBMs) in inflating costs
🏥 How nonprofit manufacturers like Civica Rx are changing the game
⚖️ The delicate balance between affordability and innovation
🧪 The real economics behind R&D and pharmaceutical investment

Whether you’re a policymaker, healthcare professional, or concerned citizen, this is a must-watch conversation on the future of medicine in America.

🔔 Don’t forget to like, comment, and subscribe for more policy deep dives.

#DrugPricing #PharmaPolicy #KelvynCullimore #BioUtah #HealthcareInnovation #PrescriptionDrugs #MostFavoredNation #PillPenalty #CivicaRx #PBMs #HealthPolicy #InflationReductionAct #BigPharma #MedicalInnovation #PoliticItPodcast #UtahLeadership #R&D #AffordableHealthcare #TransparencyInHealthcare